Biochemical characterization of a low molecular weight aspartic protease inhibitor from thermo-tolerant Bacillus licheniformis: Kinetic interactions with Pepsin

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 12, 2006, Pages 1845-1856

  Kumar, Ajit ^a   Rao, Mala ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Aspartic protease inhibitor; Bacillus licheniformis; Enzyme kinetic; Pepsin; Slow tight binding inhibition

Indexed keywords

AMINO ACID; ASPARTIC PROTEINASE INHIBITOR; PEPSIN A; PEPTIDE; TRYPTOPHAN;

ALPHA HELIX; AMINO ACID ANALYSIS; ARTICLE; BACILLUS LICHENIFORMIS; BETA SHEET; BINDING COMPETITION; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; ENZYME BINDING; ENZYME KINETICS; ENZYME STABILITY; FLUORESCENCE ANALYSIS; ISOMERIZATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TEMPERATURE; THERMOSTABILITY; TIME;

ADAPTATION, PHYSIOLOGICAL; ASPARTIC ENDOPEPTIDASES; BACILLUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KINETICS; MOLECULAR WEIGHT; PEPSIN A; PROTEASE INHIBITORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BACILLUS LICHENIFORMIS;

EID: 33750630543     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.08.004     Document Type: Article

References (48)

1. Friedman L.S., and Peterson W.L. Peptic ulcer and related disorders. In: Fauci A.S., Braunwald E., Isselbacheret K.J., et al. (Eds). Harrison's Principles of Internal Medicine. 14th ed. (1998), McGraw Hill 1596-1616
2. Thaisrivongs S. Drug News Prospect 1 (1989) 11-16
3. Debouck C., and Metcalf B.W. Human immunodeficiency virus protease a target for AIDS therapy. Drug Dev. Res. 21 (1990) 1-17
4. Rosenthal P.J. Proteases of malaria parasites: new targets for chemotherapy. Emerg. Infect. Dis. 4 (1998) 49-57
5. Scarborough P.E., Guruprasad K., Topham C., Richo G.R., Conner G.E., Blundell T.L., and Dunn B.M. Exploration of subsite binding specificity of human cathepsin D through kinetics and knowledge-based molecular modeling. Protein Sci. 2 (1993) 264-276
6. Ward M., and Kodama K.H. In: Dunn B.M. (Ed). Structure and Function of the Aspartic Proteinases Genetics, Structure, and Mechanisms (1991), Plenum Press, New York 149-160
7. Tobey N.A., Hosseini S.S., Caymaz-Bor C., Wyatt H.R., Orlando G.S., and Orlando R.C. The role of pepsin in acid injury to esophageal epithelium. Am. J. Gastroenterol. 96 (2001) 3062-3070
8. Vicki S., Erika J.K., Robert J.C., Gudmund S.B., and Peterm W.D. Inhibition of pepsin activity by alginates in vitro and the effect of epimerization. Int. J. Pharm. 304 (2005) 40-50
9. Williams J.W., and Morrison J.F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63 (1979) 437-467
10. Szedlacsek S., and Duggleby R.G. Kinetics of slow and tight-binding inhibitors. Methods Enzymol. 249 (1995) 144-180
11. Sculley M.J., Morrison J.F., and Cleland W.W. Slow-binding inhibition: the general case. Biochim. Biophys. Acta 1298 (1996) 78-86
12. Morrison J.F. The slow-binding and slow, tight-binding inhibition of enzyme-catalyzed reactions. Trends Biochem. Sci. 7 (1982) 102-105
13. Morisson J.F., and Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61 (1988) 201-301
14. Yiallouros I., Vassiliou S., Yiotakis A., Zwilling R., Stocker W., and Dive V. Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors. Biochem. J. 331 (1998) 375-379
15. Ploux O., Breyne O.b., Carillon S., and Marquet A. Slow-binding and competitive inhibition of 8-amino-7-oxopelargonate synthase, a pyridoxal-5′-phosphate-dependent enzyme involved in biotin biosynthesis, by substrate and intermediate analogs. Kinetic and binding studies. Eur. J. Biochem. 259 (1999) 63-70
16. Merker D.J., Brenowitz M., and Schramm V.L. The rate constant describing slow-onset inhibition of yeast AMP deaminase by coformycin analogs is independent of inhibitor structure. Biochemistry 29 (1990) 8358-8364
17. Pegg M.S., and Von I.M. Slow-binding inhibition of sialidase from influenza virus. Biochem. Mol. Biol. Int. 32 (1994) 851-858
18. Kati W.M., Saldivar A.S., Mohamadi F., Sham H.L., Laver W.G., and Kohlbrenner W.E. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains. Biochem. Biophys. Res. Commun. 244 (1998) 408-413
19. Suguna K., Padlan E.A., Smith C.W., Catlson W.D., and Davies D.R. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7009-7013
20. James M.N.G., Sielecki A.R., Hayakawa K., and Gelb M.H. Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. Biochemistry 31 (1992) 3872-3888
21. In: Umezawa H., Takita T., and Shiba T. (Eds). Bioactive Peptides Produced by Microorganisms (1978), Halsted, New York
22. Rich D., and Sun E. Mechanism of inhibition of pepsin by pepstatin: effect of inhibitor structure on dissociation constant and time dependent inhibition. Biochem. Pharmacol. 29 (1980) 2205-2212
23. Gelb M., Svaren J., and Abeles R. Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry 24 (1985) 1813-1817
24. Chandravanu D., Sangita P., Vasanti D., and Mala R. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes. Biochemistry 40 (2001) 11525-11532
25. Buchanan R.H., and Gibbons N.E. Bergey's Manual of Determinative Bacteriology. 8th ed. (1974), William and Wilkins Co, Baltimore 529-550
26. Le Q.T., and Katunuma N. Detection of protease inhibitors by a reverse zymography method, performed in a tris (hydroxymethyl)aminomethane-Tricine buffer system. Anal. Biochem. 324 (2004) 237-240
27. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
28. Anson M.L. The purification of cathepsin. J. Gen. Physiol. 23 (1940) 695-704
29. Dash C., and Rao M. Interactions of a novel inhibitor/from an extremophilic Bacillus sp. with HIV-1 protease: implications for the mechanism of inactivation. J. Biol. Chem. 276 (2001) 2487-2493
30. Westling J., Cipullo P., Hung S.H., Saft H., Dame J.B., and Dunn B.M. Active site specificity of plasmepsin II. Protein Sci. 8 10 (1999) 2001-2009
31. Lenney J.F. Three yeast proteins that specifically inhibit yeast proteases A, B and C. J. Bacteriol. 122 (1975) 1265-1273
32. Walsh K.A. Proteolytic enzymes. In: Perlmann G.E., and Lorand L. (Eds). Methods in Enzymology vol. 19 (1970), Academic Press, New York 41-63
33. Arnon R. Proteolytic enzymes. In: Perlmann G.E., and Lorand L. (Eds). Methods in Enzymology vol. 19 (1970), Academic Press, New York 226-244
34. Grant G.A., Eisen A.Z., and Bradshaw R.A. Proteolytic enzymes part C. In: Lorand L. (Ed). Methods in Enzymology vol. 80 (1981), Academic Press, New York 722-734
35. Ryle A.P. The porcine pepsins and pepsinogens. Methods Enzymol. 19 (1970) 316-336
36. Dixon M. Determination of enzyme-inhibitor constants. Biochem. J. 55 (1953) 170-171
37. Duggleby R.G. Progress-curve analysis in enzyme kinetics. Numerical solution of integrated rate equations. Biochem. J. 235 (1986) 613-616
38. Hindmarsh A.C. In: Stepleman R.S. (Ed). Scientific Computing (1983), North Holland, Amsterdam 55-64
39. Reich J.G. Curve Fitting and Modelling for Scientists and Engineers (1992), Graw-Hill, New York
40. Moss M.L., Kuzmic P., Stuart J.D., Tian G., Peranteau A.G., Frye S.V., Kadwell S.H., Kost T.A., Overton L.K., and Patel I.R. Inhibition of human steroid 5 α-reductases type I and II by 6-Aza-Steroids: structural determinants of one-step vs two-step. Mechanism Biochemistry 35 11 (1996) 3457-3464
41. Houtzager V., Oullet M., Falgueyret J.P., Passmore L.A., Bayly C., and Percival M.D. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2. Biochemistry 35 (1996) 10974-10984
42. Lakowicz J.R. Principles of Fluorescence Spectroscopy (1983), Plenum Press, New York
43. Williams J.W., and Morrison J.F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63 (1979) 437-467
44. Wolfenden R. Transition state analog inhibitors and enzyme catalysis. Annu. Rev. Biophys. Bioeng. 5 (1976) 271-306
45. Lenarcic B., and Turk V. Thyroglobulin Type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J. Biol. Chem. 274 (1999) 563-566
46. Jencks W.C. Binding energy, specificity and enzymic catalysis: the Circe effect. Adv. Enzymol. Relat. Areas Mol. Biol. 43 (1975) 219-411
47. Pawagi A.B., and Deber C.M. Ligand-dependent quenching of tryptophan fluorescence in human erythrocyte hexose transport protein. Biochemistry 29 4 (1990) 950-955
48. Cheung H.C. In: Lakowiez J.R. (Ed). Topics in Fluorescence Spectroscopy, Vol. 2: Principles (1991), Plenum Press, New York 127-176